446 related articles for article (PubMed ID: 17339185)
1. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls.
Quiroga T; Goycoolea M; Panes O; Aranda E; Martínez C; Belmont S; Muñoz B; Zúñiga P; Pereira J; Mezzano D
Haematologica; 2007 Mar; 92(3):357-65. PubMed ID: 17339185
[TBL] [Abstract][Full Text] [Related]
2. Investigating people with mucocutaneous bleeding suggestive of primary hemostatic defects: a low likelihood of a definitive diagnosis?
Favaloro EJ
Haematologica; 2007 Mar; 92(3):292-6. PubMed ID: 17339176
[No Abstract] [Full Text] [Related]
3. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients.
Quiroga T; Goycoolea M; Muñoz B; Morales M; Aranda E; Panes O; Pereira J; Mezzano D
J Thromb Haemost; 2004 Jun; 2(6):892-8. PubMed ID: 15140124
[TBL] [Abstract][Full Text] [Related]
4. [Skin and mucous membrane hemorrhages: clinical assessment, study sequence and relative frequency of hereditary diseases of the hemostasis in a Chilean population].
Quiroga T; Pérez M; Rodríguez S; Muñoz B; Aranda E; Morales M; Verdugo P; Pereira J; Mezzano D
Rev Med Chil; 1997 Apr; 125(4):409-18. PubMed ID: 9460281
[TBL] [Abstract][Full Text] [Related]
5. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
Shihong I; Morris D; Konkle BA
Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
[TBL] [Abstract][Full Text] [Related]
6. Laboratory assessment of familial, nonthrombocytopenic mucocutaneous bleeding: a definitive diagnosis is often not possible.
Pereira J; Quiroga T; Mezzano D
Semin Thromb Hemost; 2008 Oct; 34(7):654-62. PubMed ID: 19085766
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of Von Willebrand disease and inherited platelet function disorders amongst Indian bleeders.
Gupta PK; Charan VD; Saxena R
Ann Hematol; 2007 Jun; 86(6):403-7. PubMed ID: 17375300
[TBL] [Abstract][Full Text] [Related]
8. Von Willebrand's disease: case report and review of literature.
Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time.
Podda GM; Bucciarelli P; Lussana F; Lecchi A; Cattaneo M
J Thromb Haemost; 2007 Dec; 5(12):2393-8. PubMed ID: 18034764
[TBL] [Abstract][Full Text] [Related]
10. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study of 148 patients--a rebuttal.
Favaloro EJ
J Thromb Haemost; 2004 Dec; 2(12):2280-2; author reply 2283-5. PubMed ID: 15613055
[No Abstract] [Full Text] [Related]
11. Thrombin generation in platelet-poor plasma is normal in patients with hereditary mucocutaneous haemorrhages.
Quiroga T; Goycoolea M; Giesen PL; Morales M; Muñoz B; Aranda E; Rodríguez S; Panes O; Martínez C; Pereira J; Mezzano D
Pathophysiol Haemost Thromb; 2003; 33(1):30-5. PubMed ID: 12853710
[TBL] [Abstract][Full Text] [Related]
12. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
Giannini S; Mezzasoma AM; Leone M; Gresele P
Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
[TBL] [Abstract][Full Text] [Related]
13. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders.
Sidonio RF; Bryant PC; Di Paola J; Hale S; Heiman M; Horowitz GS; Humphrey C; Jaffray J; Joyner LC; Kasthuri R; Konkle BA; Kouides PA; Montgomery R; Neeves K; Randi AM; Scappe N; Tarango C; Tickle K; Trapane P; Wang M; Waters B; Flood VH
Expert Rev Hematol; 2023 Mar; 16(sup1):39-54. PubMed ID: 36920856
[TBL] [Abstract][Full Text] [Related]
14. The power of a standardized bleeding score in diagnosing paediatric type 1 von Willebrand's disease and platelet function defects.
Marcus PD; Nire KG; Grooms L; Klima J; O'Brien SH
Haemophilia; 2011 Mar; 17(2):223-7. PubMed ID: 20860605
[TBL] [Abstract][Full Text] [Related]
15. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease.
Favaloro EJ
Blood Rev; 1999 Dec; 13(4):185-204. PubMed ID: 10741895
[TBL] [Abstract][Full Text] [Related]
16. ISTH bleeding assessment tool and platelet function analyzer in children with mild inherited platelet function disorders.
Alhaj D; Hagedorn N; Cuntz F; Reschke M; Schuldes J; Ruthenberg J; Bakchoul T; Greinacher A; Holzhauer S
Eur J Haematol; 2024 Jul; 113(1):54-65. PubMed ID: 38549165
[TBL] [Abstract][Full Text] [Related]
17. [A diagnostic approach to relatively common mild bleeding symptoms: screening of congenital mild bleeding disorders].
Kaneko M
Rinsho Ketsueki; 2018; 59(10):2247-2254. PubMed ID: 30305532
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.
Schlammadinger A; Kerenyi A; Muszbek L; Boda Z
Thromb Haemost; 2000 Jul; 84(1):88-92. PubMed ID: 10928476
[TBL] [Abstract][Full Text] [Related]
19. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
[TBL] [Abstract][Full Text] [Related]
20. Screening women with menorrhagia for underlying bleeding disorders: the utility of the platelet function analyser and bleeding time.
Philipp CS; Miller CH; Faiz A; Dilley A; Michaels LA; Ayers C; Bachmann G; Dowling N; Saidi P
Haemophilia; 2005 Sep; 11(5):497-503. PubMed ID: 16128894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
